New Parkinson’s Treatment Approved by FDA

Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on treatment for Parkinson’s sufferers.  Xadago is designed to help patients who experience “off” episodes where their primary medication is not working well.  During these “off” periods, Parkinson’s symptoms, such as tremors and walking problems, may increase.  Xadago is supposed to help.

Parkinson’s is a neurological disorder that occurs when cells in the brain that produce dopamine become impaired or die.  Dopamine is a brain chemical that helps transmit signals between areas of the brain that produce smooth, purposeful movements – like for eating, writing, shaving, etc.  According to the National Institutes of Health, about 50,000 new cases are diagnosed each year in the U.S. and approximately 1 million are currently battling this disease.  Dr. Eric Bastings of the FDA describes Parkinson’s disease as “relentless without a cure.”  While there is no cure, Dr. Bastings noted that the FDA is “committed to helping make additional treatments for Parkinson’s available to patients.“

If you suffer from Parkinson’s disease, you should speak with your neurologist about whether or not Xadago may offer you relief. 

You can read the full FDA titled FDA approves drug to treat Parkinson's disease.

Loyd J. Bourgeois
Connect with me
Disability and Personal Injury Attorney
Be the first to comment!
Post a Comment